TALDEX

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUNRISE REMEDIES

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 50 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUNRISE REMEDIES

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 40 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: SUNRISE REMEDIES

CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: CENTURION LABORATORIES

CLASSIFICATION: PDE5 INHIBITOR (ERECTILE DYSFUNCTION AGENT)
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 TABLETS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: 10–20 MG AS NEEDED
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): MAY LOWER
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS